Markets & Future Prospects for Cell & Gene Therapy

The enormous number of companies involved in Cell Therapy has increased progression remarkably during the past few years. More than 500 companies have been identified to be involved in cell therapy and 305 of these are profiled 291 alliances. Of these companies, 170 are involved in stem cells. The Profiles of 72 academic institutions in the US involved in cell therapy along with their commercial collaborations. Allogeneic technology with more than 350 clinical trials is poised to dominate the commercialization of cell therapies in market. Further RandD in cell and gene therapy is expected to bloom given the biologically based advantages.

 


 

  • scope of cell and gene therapy
  • growth rate of cell and gene therapy

Related Conference of Markets & Future Prospects for Cell & Gene Therapy

July 19-20, 2021

25th Global Congress on Biotechnology

Vienna, Austria
August 06-07, 2021

International Conference on Plant Genomics

London, UK
August 13-14, 2021

36th International Conference on Immunology & Immunogenetics

Edinburgh, Scotland
September 13-14, 2021

4th Annual Summit on Cell and Gene Therapy

Prague, Czech Republic
September 22-23, 2021

13th World Congress on Cell and Stem Cell Research

Madrid, Spain
September 27-28, 2021

15th International Conference on Genomics & Pharmacogenomics

Vancouver, Canada
October 18-19, 2021

20th International Conference on Structural Biology

Rome, Italy
November 20-21, 2021

26th World Congress on Industrial Biotechnology

Chicago, USA
December 07-08, 2021

2nd World Congress on Cell and Structural Biology

Sydney, Australia
December 09-10, 2021

2nd International Conference on Geriatrics and Ageing

Sydney, Australia

Markets & Future Prospects for Cell & Gene Therapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in